Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Treatment Program for Anemia in AIDS Patients Clinical Trials Resources presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, visits or professional assistance with a real medical. We aren't doctors. Always consult your mD about Treatment Program for Anemia in AIDS Patients conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Treatment Program for Anemia in AIDS Patients Clinical research trials and Treatment Program for Anemia in AIDS Patients health trials occur in a lot of of places throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / projects is to resolve certain human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to detect remedies for all varieties of circumstances, such as Treatment Program for Anemia in AIDS Patients. Treatment Program for Anemia in AIDS Patients Clinical Trials and other clinical trials allow volunteers to obtain health treatment choices before they are available to the general public. Most times the human subjects recieve professional assistance for free of charge, and every now and again they are paid for their time. Sometimes there is a cost for a Treatment Program for Anemia in AIDS Patients clinical trial. Human subjects frequently get the finest healthcare available for their Treatment Program for Anemia in AIDS Patients condition. Risks are a reality, however, and may include extra or frequent physician visits, medical dangers (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with strict guidelines to protect clinical trials patients.

Home > "T" Clinical Trials Conditions > Treatment Program for Anemia in AIDS Patients

Treatment Program for Anemia in AIDS Patients



Treatment Program for Anemia in AIDS Patients

For Condition: HIV Infections,Cytopenias
Status: Completed
Sponsor(s): R W Johnson Pharmaceutical Research Institute ,
Synopsis: The objective of the Eprex (erythropoietin) Treatment Program is to provide erythropoietin for the treatment of anemia in AIDS patients.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Dose Comparison
Minimum Age/Maximum Age: 12 Years/
Genders: Both
Protocol Entry Criteria: Exclusion Criteria Co-existing Condition: Patients with the following are excluded: - Life expectancy < 3 months. - = or < grade 4 performance score. - AIDS-related dementia. - Uncontrolled hypertension. - Acute symptomatic opportunistic infection or other AIDS-defining illness. Patients with the following are excluded: - Life expectancy < 3 months. - = or < grade 4 performance score. - AIDS-related dementia. - Uncontrolled hypertension. - Acute symptomatic opportunistic infection or other AIDS-defining illness. Patients must have: - A clinical diagnosis of AIDS. - Hematocrit < 30 percent. - Endogenous serum erythropoietin level = or < 500 U/ml. - A life expectancy = or > 3 months. - > Grade 4 performance score.
Total Enrollment: 

Location and Contact Information:

R W Johnson Pharmaceutical Research Institute
Raritan,  New Jersey,  088690602
United States
 


Additional Information:
Study ID Numbers:
  004G;  I88-083
Study Start Date: 
Record last reviewed: February 1991
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002022

Other Cytopenias Studies:
1. A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

2. A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients with AIDS or AIDS-Related Complex

3. A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine

4. Treatment Program for Anemia in AIDS Patients

5. A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

Related Studies:

Other Cytopenias Clinical Trials
Other New Jersey Clinical Trials
Other Raritan Clinical Trials

Treatment Program for Anemia in AIDS Patients

Modify your Search

  Other Cytopenias Clinical Trials
  Other New Jersey Clinical Trials
  Other Raritan Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103